Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial. [electronic resource]
Producer: 20150413Description: 1220-7 p. digitalISSN:- 1592-8721
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Child
- Child, Preschool
- Dexamethasone -- administration & dosage
- Female
- Humans
- Immunophenotyping
- Induction Chemotherapy
- Infant
- Infant, Newborn
- Male
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- diagnosis
- Prednisolone -- administration & dosage
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.